Literature DB >> 9605390

Muscle pathology in the early stage of Guillain-Barré syndrome.

S Ono1, K Inoue, S Munakata, K Nagao, N Shimizu.   

Abstract

Although many studies have been performed on nervous tissue pathology in Guillain-Barré syndrome (GBS), much less is known about pathological changes in skeletal muscle in this disorder. We have studied muscle biopsies from 5 patients with GBS, 5 patients with amyotrophic lateral sclerosis (control A), and 5 patients with polyarteritis nodosa (control B). We also examined muscle obtained after death from 7 patients without neurologic or muscular diseases (control C). By light microscopy, all specimens from patients with GBS exhibited necrosis and/or phagocytosis, none of which was observed in the other three controls. Neither small angulated fibers nor small group atrophy was found in patients with GBS and in control C, by contrast with controls A and B. Ultrastructurally, filamentous bodies, subsarcolemmal aggregates of mitochondria, accumulation of glycogen particles, and concentric laminated bodies were present much more frequently in patients with GBS than in all controls. Only GBS patients showed cytoplasmic bodies. These observation suggests that there is muscle involvement in the early stage of GBS and that these muscle changes may have an intimate and important relationship to the pathogenesis of GBS.

Entities:  

Mesh:

Year:  1998        PMID: 9605390     DOI: 10.1159/000007924

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  1 in total

1.  Metabolic Profile and Pathological Alterations in the Muscle of Patients with Early-Stage Amyotrophic Lateral Sclerosis.

Authors:  Débora Lanznaster; Clément Bruno; Jérôme Bourgeais; Patrick Emond; Ilyess Zemmoura; Antoine Lefèvre; Pascal Reynier; Sébastien Eymieux; Emmanuelle Blanchard; Patrick Vourc'h; Christian R Andres; Salah Eddine Bakkouche; Olivier Herault; Luc Favard; Philippe Corcia; Hélène Blasco
Journal:  Biomedicines       Date:  2022-06-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.